Skip to main content
California Lawyers Association Logo
Visit cla Website
Browse by
Delivery Type browse by
  • Calendar

  • CLEtoGo (Podcasts) (2076)
  • Webcast (4)
  • Zoom Webinar (13)
  • OnDemand (2185)
  • Self Study Articles (137)
     
Hello, Guest
Sign in Browse By
  • Sign In
    New Customer? Start Here

  • Frequently Asked Questions
0
Cart
loading...
Event Date Search
  
Postal Code Search
   
Speaker Search
Credits Search
  • Home
  • »
  • Intellectual Property Law 
  • »
  • Product Details
You must select a location to proceed.
Yes
No
There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
Adding Registration Loading Image Adding Registration, Please wait...
You must be logged in to perform this action.
Log in
Cancel
OnDemand

Practical Impact of SCOTUS’s decision in Helsinn v. Teva on Secret Sales


Intellectual Property Law Section, Patent Interest Group
Credit(s): 0.75 Participatory MCLE Credits
Course Number: IP_02-25-19
Original Program Date: February 25, 2019
Duration: 44 minutes
Access: Available for 3 months after Registration
Passport: This product is Passport Eligible 
  • Facebook
  • LinkedIn
  • X
  • E-Mail
    • Description
    • Sessions
    • Credits
    • Faculty
    • Materials
    • Reviews
    • Dates and Locations
    • Pricing
    Category: Intellectual Property Law
    Category: Intellectual Property Law (show less)
    In Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., the   U.S. Supreme Court affirmed the Federal Circuit’s interpretation of the “on   sale bar” — holding that “Congress did not alter the meaning of ‘on sale’   when it enacted the AIA.” In so doing, the Supreme Court answered   affirmatively that a secret sale of an invention, or a sale of a technology   under terms that require the invention to remain confidential, is barred   under 35 U.S.C. § 102(a)(1), thereby preventing the invention from being   patented. In this webinar, our panelists will weigh in on the impact of this   decision and offer practical pointers to stakeholders and practitioners when   dealing with secret, on-sale offers, activities, or commercialization.
    0.75 Participatory MCLE Credits

    Customers Who Bought This Item Also Bought

    Screen Cap
    (OnDemand)
    Got Priority? What you need to know to avoid pitfalls and loss of priority rights in Europe
    Screen Cap
    (OnDemand)
    The End of Life Option Act: How it Works In The Real World
    Screen Cap
    (CLEtoGo (Podcasts))
    Antitrust Implications of Healthcare Provider Consolidation
    Screen Cap
    (OnDemand)
    45th Annual IP Institute: The Changing Climate on Pharma Patents, Healthcare Investment, and Drug Pricing & Accessibility
    Screen Cap
    (OnDemand)
    Got Priority? What you need to know to avoid pitfalls and loss of priority rights in Europe
    Screen Cap
    (OnDemand)
    The End of Life Option Act: How it Works In The Real World
    Screen Cap
    (CLEtoGo (Podcasts))
    Antitrust Implications of Healthcare Provider Consolidation
    Screen Cap
    (OnDemand)
    45th Annual IP Institute: The Changing Climate on Pharma Patents, Healthcare Investment, and Drug Pricing & Accessibility
    Screen Cap
    (OnDemand)
    Got Priority? What you need to know to avoid pitfalls and loss of priority rights in Europe
    Screen Cap
    (OnDemand)
    The End of Life Option Act: How it Works In The Real World
    Screen Cap
    (CLEtoGo (Podcasts))
    Antitrust Implications of Healthcare Provider Consolidation
    Screen Cap
    (OnDemand)
    45th Annual IP Institute: The Changing Climate on Pharma Patents, Healthcare Investment, and Drug Pricing & Accessibility
    PrevNext

    Purchase Options

    Add to CartOnDemand
    $33.75
    Show all Prices
    We are committed to accessibility! All OnDemand programs after January 1, 2022 include closed captioning. To request closed captioning for a program older than January 1, 2022, send us a note at accessibility@calawyers.org or contact us at 916-516-1760 for assistance.
    Have a Question?
    See our FAQ's
    Privacy Policy
    Contact us at (877) 880-1335
    Email Us

    CCPA & GDPR